Product Details for: Enjaymo

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
1,100MG/22ML (50MG/ML)
Single-Dose Vial
351(a)
Enjaymo
Rx
Proper Name
sutimlimab-jome
BLA Number
761164
Applicant
Recordati Rare Diseases, Inc.
Original Approval Date
February 4, 2022
Date of First Licensure
RETURN TO SEARCH RESULTS